Red White & Bloom Provides Update Relating to Aleafia Health
November 22, 2023
Drug Manufacturers
-
-
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders’ Equity of $44.2M or $3.4/Share
November 21, 2023
-
City Trees Announces New Market Venture in New Mexico Through Licensing Agreement.
November 15, 2023
-
Endexx Initiates TPD Registration in Europe
November 14, 2023
-
Red White & Bloom Launches Platinum® in Ohio Following Successful Vote for Adult-Use Marijuana Legalization
November 9, 2023
-
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License
November 7, 2023
-
Petros Pharmaceuticals Petros Pharmaceuticals Developing Artificial Intelligence Technology for Phase 2 Equivalent Study for STENDRA(R)
October 30, 2023
-
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
October 26, 2023
-
22nd Century Announces Pricing of $5.25 Million Public Offering
October 17, 2023
-
Endexx Secures Reorder for Non-Nicotine Vape Product HYLA From Italy
October 12, 2023
-
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders
October 11, 2023
-
Curaleaf Applies to List Subordinate Voting Shares on the Toronto Stock Exchange
October 10, 2023
-
Petros Pharmaceuticals Announces Positive Outcomes in Label Comprehension Study for Potential OTC STENDRA Label
October 4, 2023
-
Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise
October 2, 2023
-
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company
September 27, 2023
-
Endexx Announces Amended Consolidated 10-Q/A: Quarterly Report for The Quarter Ending March 31, 2023, Increasing Year-Over-Year 1013%
September 19, 2023